Department of Surgery, Academic Hospital of Maastricht, 6202-AZ Maastricht, The Netherlands.
Gastroenterol Res Pract. 2011;2011:186350. doi: 10.1155/2011/186350. Epub 2011 Jul 26.
Background. In this prospective randomised study, the staged mucosal advancement flap is compared with staged fibrin sealant application in the treatment of perianal fistulas. Methods. All patients with high complex cryptoglandular fistulas were randomised to closure of the internal opening by a mucosal advancement flap (MF) or injection with fibrin sealant (FS) after treatment with setons. Recurrence rate and incontinence disorders were explored. Results. The MF group (5 females and 10 males) with a median age of 51 years and a median followup of 52 months. The FS group (4 females and 11 males) with a median age of 45 years and a median followup of 49 months. Three (20%) patients of the MF group had a recurrent fistula compared to 9 (60%) of the FS group (P = 0.03). No new continence disorders developed. Conclusion. Staged FS injection has a much lower success rate compared to MF.
在这项前瞻性随机研究中,分期黏膜推进瓣与分期纤维蛋白胶应用在治疗肛周瘘中的疗效进行了比较。
所有高位复杂性肛隐窝瘘患者均接受切开挂线治疗,随机分为黏膜推进瓣(MF)组(5 名女性和 10 名男性)和纤维蛋白胶(FS)组(4 名女性和 11 名男性)。MF 组患者经 MF 关闭内口,FS 组患者经 FS 注射关闭内口。探讨复发率和失禁障碍。
MF 组(5 名女性和 10 名男性)中位年龄 51 岁,中位随访 52 个月。FS 组(4 名女性和 11 名男性)中位年龄 45 岁,中位随访 49 个月。MF 组有 3 例(20%)患者复发,FS 组有 9 例(60%)患者复发(P = 0.03)。没有新发的失禁障碍。
分期 FS 注射的成功率明显低于 MF。